Skip to content

Tissue Microdialysis Monitoring of Liver Grafts

Clinical Applicability of Tissue Microdialysis for Early Assessment of Liver Graft Metabolism in Patients After Orthotopic Liver Transplantation

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06890234
Enrollment
25
Registered
2025-03-21
Start date
2022-05-11
Completion date
2025-12-31
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Graft Dysfunction, Liver Transplantation, Tissue Metabolism

Keywords

microdialysis, liver graft monitoring

Brief summary

This study will investigate the dynamics of metabolic molecules sampled from human liver grafts during the early postoperative period using tissue microdialysis. The obtained tissue samples will be compared with standard liver function tests and dynamic functional liver assessment tests. The primary objective is to evaluate the clinical feasibility, utility, and non-inferiority of tissue microdialysis in comparison to current standard methods for monitoring liver grafts.

Interventions

None listed

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients aged between 18 and 65 years. * Liver transplant candidates on the Slovenian liver transplant waiting list, matched with an available liver graft through the Eurotransplant system, and scheduled for the surgical procedure. * Signed informed consent to participate in the microdialysis sampling research project, including consent to share the obtained samples with other research studies

Exclusion criteria

* Patients under 18 or over 65 years of age. * Refusal to participate in the study. * Verbal withdrawal of consent at any point during the study, even if informed consent has been previously signed. * Surgical contraindications preventing the insertion of a microdialysis catheter into the liver graft during the procedure. * Surgical revision within 48 hours post-transplantation resulting in liver graft loss and removal. * History of allergic reactions to radiographic contrast media. * Death during the liver transplant procedure.

Design outcomes

Primary

MeasureTime frameDescription
The agreement between microdialysis-derived metabolite levels and conventional liver function testsFrom the end of liver transplant surgery up to 5 days post-transplantThe correlation between tissue microdialysis metabolites (glucose, pyruvate, lactate, glycerol, urea) and standard static and dynamic liver function tests (ALT, AST, bilirubin, INR, plasma lactate, plasma pyruvate, and indocyanine green \[ICG\] clearance) in the early post-transplant period.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026